Edwin Velez
About Edwin Velez
Edwin Velez is the Director, Cell Therapy Global Business Process Owner at Bristol Myers Squibb, with over 25 years of experience in Chemical Engineering.
Company
Edwin Velez is currently employed at Bristol Myers Squibb, a globally recognized biopharmaceutical company. At Bristol Myers Squibb, Edwin holds the position of Director, Cell Therapy Global Business Process Owner. The company is known for its innovative work in developing treatments for serious diseases, including their significant contributions to the cell therapy sector.
Title
Edwin Velez serves as the Director, Cell Therapy Global Business Process Owner. In his role, he is responsible for overseeing and optimizing business processes related to cell therapy, a cutting-edge area in medical treatment that involves modifying patient cells to fight diseases like cancer.
Education and Expertise
Edwin Velez studied at RUM (University of Puerto Rico, Mayagüez Campus), where he earned a Bachelor of Science degree in Chemical Engineering. He completed his studies between 1990 and 1995. Over the years, he has accrued more than 25 years of experience in chemical engineering, particularly within the pharmaceutical industry. Edwin's extensive expertise includes a deep understanding of global business processes in the context of cell therapy.
Background
Edwin Velez has a professional background rooted in chemical engineering, with over 25 years of experience in the field. He began his education at the University of Puerto Rico, Mayagüez Campus, where he studied from 1990 to 1995. Currently based in New Brunswick, New Jersey, Edwin plays a significant role in the cell therapy sector, contributing his extensive knowledge in global business processes to Bristol Myers Squibb.
Achievements
Edwin Velez's notable achievements include his appointment as Director, Cell Therapy Global Business Process Owner at Bristol Myers Squibb in August 2020. His role is critical in advancing and optimizing cell therapy business processes on a global scale. Edwin's career spans over two decades, during which he has built a solid reputation for his expertise in chemical engineering and the pharmaceutical industry.